DZ1323A1 - Dérivé du pyrolle. - Google Patents

Dérivé du pyrolle.

Info

Publication number
DZ1323A1
DZ1323A1 DZ890021A DZ890021A DZ1323A1 DZ 1323 A1 DZ1323 A1 DZ 1323A1 DZ 890021 A DZ890021 A DZ 890021A DZ 890021 A DZ890021 A DZ 890021A DZ 1323 A1 DZ1323 A1 DZ 1323A1
Authority
DZ
Algeria
Prior art keywords
pyrolle
derived
Prior art date
Application number
DZ890021A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888803048A external-priority patent/GB8803048D0/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DZ1323A1 publication Critical patent/DZ1323A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
DZ890021A 1988-02-10 1989-02-08 Dérivé du pyrolle. DZ1323A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888803048A GB8803048D0 (en) 1988-02-10 1988-02-10 Substituted pyrroles
GB888827565A GB8827565D0 (en) 1988-02-10 1988-11-25 Substituted pyrroles

Publications (1)

Publication Number Publication Date
DZ1323A1 true DZ1323A1 (fr) 2004-09-13

Family

ID=26293462

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ890021A DZ1323A1 (fr) 1988-02-10 1989-02-08 Dérivé du pyrolle.

Country Status (22)

Country Link
US (1) US5057614A (fr)
EP (1) EP0328026B1 (fr)
JP (1) JPH0730071B2 (fr)
AU (1) AU623630B2 (fr)
CA (1) CA1320194C (fr)
CZ (1) CZ280738B6 (fr)
DE (1) DE58904168D1 (fr)
DK (1) DK171891B1 (fr)
DZ (1) DZ1323A1 (fr)
ES (1) ES2054890T3 (fr)
FI (1) FI96861C (fr)
HU (1) HU201054B (fr)
IE (1) IE63489B1 (fr)
IL (1) IL89167A (fr)
IS (1) IS1941B (fr)
MC (1) MC2010A1 (fr)
NO (1) NO172540C (fr)
NZ (1) NZ227850A (fr)
PH (1) PH25185A (fr)
PT (1) PT89661B (fr)
SK (1) SK75289A3 (fr)
YU (1) YU47101B (fr)

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC2096A1 (fr) * 1989-02-23 1991-02-15 Hoffmann La Roche Pyrroles substitues
GB8904161D0 (en) * 1989-02-23 1989-04-05 Hoffmann La Roche Substituted pyrroles
DE3914764A1 (de) * 1989-05-05 1990-11-08 Goedecke Ag Maleinimid-derivate und deren verwendung als arzneimittel
CA2015996C (fr) * 1989-05-05 2001-08-28 Hartmut Osswald Derives de bis-(1h-indole-3-yl)-maleinimide et leur utilisation comme produits pharmaceutiques
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DE4005970A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte maleinimide, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles
CA2046801C (fr) * 1990-08-07 2002-02-26 Peter D. Davis Pyrroles substitues
GB9123396D0 (en) * 1991-11-04 1991-12-18 Hoffmann La Roche A process for the manufacture of substituted maleimides
AU3761393A (en) * 1992-03-20 1993-10-21 Wellcome Foundation Limited, The Indole derivatives with antiviral activity
US5290777A (en) * 1993-02-24 1994-03-01 Regents Of The Univ. Of California Use for topsentin compounds and pharmaceutical compositions containing same
US5721230A (en) * 1993-05-10 1998-02-24 Hoffmann-La Roche Inc. Substituted pyrroles
AU678435B2 (en) * 1993-05-10 1997-05-29 F. Hoffmann-La Roche Ag Substituted pyrroles
US5405864A (en) * 1993-10-15 1995-04-11 Syntex (U.S.A.) Inc. Chemotherapeutic maleimides
TW270114B (fr) * 1993-10-22 1996-02-11 Hoffmann La Roche
DK0657411T3 (da) * 1993-12-07 1999-11-15 Lilly Co Eli Forbedret syntese af bisindolylmaleimider
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
DE69428025T2 (de) * 1993-12-07 2002-05-29 Lilly Co Eli Proteinkinase C-Inhibitoren
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5541347A (en) * 1993-12-07 1996-07-30 Eli Lilly And Company Synthesis of bisindolylmaleimides
AU1339895A (en) * 1993-12-23 1995-07-10 Eli Lilly And Company Protein kinase c inhibitors
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
WO1995034307A1 (fr) * 1994-06-14 1995-12-21 Sloan-Kettering Institute For Cancer Research Proteine kinase activee par ceramides et procedes d'utilisation d'effecteurs
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
EP0695755B1 (fr) * 1994-08-04 1998-10-21 F. Hoffmann-La Roche AG Pyrrolocarbazole
US5705511A (en) * 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
US5594009A (en) * 1994-10-14 1997-01-14 Cephalon, Inc. Fused pyrrolocarbazoles
US5475110A (en) * 1994-10-14 1995-12-12 Cephalon, Inc. Fused Pyrrolocarbazoles
US5591855A (en) * 1994-10-14 1997-01-07 Cephalon, Inc. Fused pyrrolocarbazoles
US5559228A (en) * 1995-03-30 1996-09-24 Eli Lilly And Company Synthesis of bisindolylmaleimides
WO1997009339A1 (fr) * 1995-09-05 1997-03-13 Banyu Pharmaceutical Co., Ltd. Derives antitumoraux d'indolopyrrolocarbazole
NZ323571A (en) * 1995-11-20 1998-12-23 Lilly Co Eli Protein kinase c inhibitor
US5616724A (en) * 1996-02-21 1997-04-01 Cephalon, Inc. Fused pyrrolo[2,3-c]carbazole-6-ones
BR9710648A (pt) * 1996-03-20 1999-08-17 Lilly Co Eli S¡ntese de indolilmaleimidas
IL126837A0 (en) 1996-05-01 1999-09-22 Lilly Co Eli Therapeutic treatment for vegf related diseases
US6232299B1 (en) 1996-05-01 2001-05-15 Eli Lilly And Company Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
UA54427C2 (uk) * 1996-05-01 2003-03-17 Елі Ліллі Енд Компані Спосіб лікування очних захворювань, які пов'язані з фактором васкулярного ендотеліального росту
PE91498A1 (es) * 1996-07-29 1998-12-22 Hoffmann La Roche Pirroles sustituidos
PE91598A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91698A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
US6093709A (en) * 1996-08-22 2000-07-25 Eli Lilly And Company Therapeutic treatment for sexual dysfunctions
NZ334030A (en) * 1996-08-23 2000-08-25 Lilly Co Eli Synthesis of bisindolylmalimides
US6107327A (en) * 1996-08-30 2000-08-22 Eli Lilly And Company Therapeutic treatment for HIV infection
US5962446A (en) * 1996-08-30 1999-10-05 Eli Lilly And Company Therapetutic treatment for human T cell lymphotrophic virus type 1 infection
SE9603284D0 (sv) * 1996-09-10 1996-09-10 Astra Ab New compounds
SE9603283D0 (sv) * 1996-09-10 1996-09-10 Astra Ab New compounds
TW472045B (en) * 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
ES2212814T3 (es) * 1996-10-31 2004-08-01 Harbor Branch Oceanographic Institution, Inc. Uso de compuestos y composiciones antiinflamatorias neurogenicas.
US5859261A (en) * 1997-03-20 1999-01-12 Eli Lilly And Company Synthesis of indolylmaleimides
US6093740A (en) * 1997-04-30 2000-07-25 Eli Lilly And Company Therapeutic treatment for skin disorders
US6133452A (en) * 1997-08-22 2000-10-17 Eli Lilly And Company Synthesis of bisindolylmalimides
AR017200A1 (es) 1997-12-23 2001-08-22 Astrazeneca Ab Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos
AU2548699A (en) * 1998-02-23 1999-09-06 Rei Asakai Cell death inhibitors
US6103712A (en) * 1998-03-05 2000-08-15 Eli Lilly And Company Therapeutic treatment for asthma
US6103713A (en) * 1998-03-05 2000-08-15 Eli Lilly And Company Therapeutic treatment for autoimmune diseases
US6291446B1 (en) 1998-03-05 2001-09-18 Eli Lilly And Company Therapeutic treatment for cytomegalovirus infection
US6225301B1 (en) 1998-03-05 2001-05-01 Eli Lilly And Company Therapeutic treatment for renal dysfunction
SE9800835D0 (sv) 1998-03-13 1998-03-13 Astra Ab New Compounds
RS49965B (sr) * 1998-03-17 2008-09-29 F.Hoffmann-La Roche Ag., Supstituisani bisindolmaleimidi za inhibiciju ćelijske proliferacije
SE9802538D0 (sv) * 1998-07-13 1998-07-13 Astra Ab New pharmaceutically active compounds
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
AU6111699A (en) * 1998-10-08 2000-05-01 Smithkline Beecham Plc Novel method and compounds
US6719520B2 (en) 1998-10-08 2004-04-13 Smithkline Beecham Corporation Method and compounds
GB9828640D0 (en) * 1998-12-23 1999-02-17 Smithkline Beecham Plc Novel method and compounds
CN100415743C (zh) * 1999-03-31 2008-09-03 韦尔纳利斯有限公司 嘧啶并[6,1-a] 异喹啉-4-酮衍生物
US6492406B1 (en) 1999-05-21 2002-12-10 Astrazeneca Ab Pharmaceutically active compounds
US6284783B1 (en) 1999-06-09 2001-09-04 The Uab Research Foundation Use of bisindolylmaleimide compounds to induce Fas-mediated apoptosis
US6346625B1 (en) 1999-06-23 2002-02-12 Astrazeneca Ab Protein kinase inhibitors
EP1224932A4 (fr) * 1999-08-20 2002-10-16 Sagami Chem Res Medicaments inhibant la mort cellulaire
US6559164B1 (en) 1999-10-12 2003-05-06 Hoffmann-La Roche Inc. Substituted pyrroles suitable for continuous infusion
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
GB0008264D0 (en) * 2000-04-04 2000-05-24 Smithkline Beecham Plc Novel method and compounds
US6326501B1 (en) * 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate
CA2308994A1 (fr) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Composes neuroprotecteurs
US7129250B2 (en) * 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
US6353007B1 (en) * 2000-07-13 2002-03-05 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents
MXPA03000695A (es) * 2000-07-27 2003-06-04 Hoffmann La Roche Derivados de 3-indolil-4-fenil-1h-pirrol-2,5-diona como inhibidores de la glucogeno sintasa quinasa-3beta.
US6482847B2 (en) * 2000-10-03 2002-11-19 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
US6469179B1 (en) * 2000-10-03 2002-10-22 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
AU2002221810B2 (en) * 2000-11-07 2005-06-23 Novartis Ag Indolylmaleimide derivatives as protein kinase C inhibitors
US6645970B2 (en) 2000-11-07 2003-11-11 Novartis Ag Indolylmaleimide derivatives
ES2263681T3 (es) * 2000-12-08 2006-12-16 Ortho-Mcneil Pharmaceutical, Inc. Compuestos de pirrolina indazolil-substituidos como inhibidores de la kinasa.
US6548531B2 (en) * 2001-02-09 2003-04-15 Hoffmann-La Roche Inc. Method for cancer therapy
DE10109280A1 (de) * 2001-02-26 2002-09-05 Peter Mayser Indolderivate mit inhibitorischer Wirkung auf Proteinkinasen
WO2002102373A1 (fr) * 2001-06-15 2002-12-27 F. Hoffmann-La Roche Ag Procede d'administration d'un agent destine a la therapie du cancer
TWI335221B (en) 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
US20030143185A1 (en) * 2001-10-29 2003-07-31 Shearwater Corporation Polymer conjugates of protein kinase C inhibitors
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
US7491716B2 (en) 2002-03-05 2009-02-17 Eli Lilly And Company Purine derivatives as kinase inhibitors
JP2005530707A (ja) * 2002-03-08 2005-10-13 イーライ・リリー・アンド・カンパニー キナーゼ阻害物質
AR039209A1 (es) 2002-04-03 2005-02-09 Novartis Ag Derivados de indolilmaleimida
EP1900738A3 (fr) * 2002-05-08 2008-04-09 Janssen Pharmaceutica, N.V. Inhibiteurs substitués de la pyrroline kinase
ES2300573T3 (es) * 2002-05-08 2008-06-16 Janssen Pharmaceutica Nv Inhibidores de cinasa sustituidos con pirrolina.
JP2005531609A (ja) 2002-06-05 2005-10-20 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ キナーゼ阻害剤としてのシスインドリル−マレイミド誘導体
ES2312785T3 (es) * 2002-06-05 2009-03-01 Janssen Pharmaceutica Nv Pirrolinas sustituidas utiles como inhibidores de quinasa.
CA2393720C (fr) * 2002-07-12 2010-09-14 Eli Lilly And Company Monochlorhydrate de 3-(1-methyl-1h-indol-3-yl)-4-[[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole-2,5-dione cristallin
US6800655B2 (en) * 2002-08-20 2004-10-05 Sri International Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
GB0303319D0 (en) * 2003-02-13 2003-03-19 Novartis Ag Organic compounds
JP2006521386A (ja) * 2003-03-27 2006-09-21 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ キナーゼ阻害剤である置換ピロリン
DE602004016174D1 (de) * 2003-06-13 2008-10-09 Janssen Pharmaceutica Nv Substituierte indazolyl(indolyl)maleimid-derivate als kinase inhibitoren
JP2007501774A (ja) 2003-08-08 2007-02-01 ノバルティス アクチエンゲゼルシャフト スタウロスポリンを含む組み合わせ
CA2552740A1 (fr) * 2004-01-19 2005-07-28 Novartis Ag Derives indolylmaleimide utilises en tant qu'inhibiteurs de la pkc
JP2007532506A (ja) * 2004-04-08 2007-11-15 ノバルティス アクチエンゲゼルシャフト 自己免疫疾患および拒絶反応の処置のためのタンパク質キナーゼｃ阻害剤
EP1765313A2 (fr) 2004-06-24 2007-03-28 Novartis Vaccines and Diagnostics, Inc. Composes utilises pour l'immunopotentialisation
US8008320B2 (en) * 2004-12-08 2011-08-30 Johannes Gutenberg-Universitatis 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
EP1846016A2 (fr) * 2005-01-04 2007-10-24 The Board Of Trustees Of The Leland Stanford Junior University Methodes permettant d'augmenter le debit sanguin cerebral
CN101133055B (zh) 2005-02-09 2011-05-25 艾科优公司 用于治疗癌症的meleimide衍生物、药物组合物以及方法
PT1904482E (pt) * 2005-07-11 2011-04-01 Novartis Ag Derivados de indolilmaleimida
WO2007027974A1 (fr) * 2005-09-02 2007-03-08 The Board Of Trustees Of The Leland Stanford Junior University Methode destinee a reduire le risque et l'etendue d'une lesion due a un accident cerebrovasculaire chez des sujets hypertendus
PE20070435A1 (es) 2005-09-16 2007-06-13 Schering Corp Formulacion farmaceutica que comprende temozolomida y un inhibidor de la proteina quinasa
WO2008077138A1 (fr) * 2006-12-19 2008-06-26 The Board Of Trustees Of The University Of Illinois 3-benzofuranyl-4-indolyl maléimides en tant qu'inhibiteurs de gsk3 puissants pour troubles neurodégénératifs
CN101801969B (zh) * 2007-06-22 2014-10-29 艾科尔公司 治疗癌症的吲哚基吡咯烷
JP5425060B2 (ja) * 2007-06-22 2014-02-26 アークル インコーポレイテッド ピロリジノン、ピロリジン−２，５−ジオン、ピロリジンおよびチオスクシンイミド誘導体、癌の治療のための組成物および方法
US8232285B2 (en) * 2007-06-22 2012-07-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
FR2927075A1 (fr) * 2008-02-04 2009-08-07 Centre Nat Rech Scient Molecules comprenant un squelette bis-(heteroaryl)maleimide, et leur utilisation dans l'inhibition d'enzymes
US8304421B2 (en) * 2008-09-30 2012-11-06 Vanderbilt University Indole compounds and their use as radiation sensitizing agents and chemotherapeutic agents
EP2338486A1 (fr) 2009-12-18 2011-06-29 Johannes Gutenberg-Universität Mainz Dérivés de 3-(indolyl)- ou de 3-(azaindolyl)-4-arylmaléimide pour usage dans le traitement de l'adenocarcinome du colon et de l'estomac
EP2343291A1 (fr) 2009-12-18 2011-07-13 Johannes Gutenberg-Universität Mainz Composés de 3-(indolyl)- ou 3-(azaindolyl)-4-arylmaléimide et leur utilisation dans le traitement de tumeurs
EP2474541A1 (fr) 2010-12-23 2012-07-11 Johannes- Gutenberg-Universität Mainz Composés conjugués de 3-(indolyl)- et 3-(azaindolyl)-4-arylmaléimide et leur utilisation dans le traitement de tumeurs
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
JP2016504299A (ja) * 2012-12-10 2016-02-12 セントジーン アーゲー 白血病を予防および治療するためのマレイミド誘導体の使用
WO2014090396A2 (fr) * 2012-12-10 2014-06-19 Centogene Ag Utilisation de dérivés de maléimide pour la prévention et le traitement du cancer
CN103382199A (zh) * 2013-06-28 2013-11-06 北京理工大学 一种n-烷基-双吲哚马来酰亚胺的制备方法
US20170209488A1 (en) 2014-07-17 2017-07-27 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (fr) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes et compositions pharmaceutiques de traitement d'infections virales
EP3187495A1 (fr) 2015-12-30 2017-07-05 Johannes Gutenberg-Universität Mainz Composés de 3-(5-fluoroindolyl)-4-arylmaléimide et leur utilisation dans le traitement de tumeurs
CN105777751B (zh) * 2016-04-26 2018-12-11 浙江工业大学 一种双芳基马来酰亚胺类化合物及其药学上可接受的盐及其制备方法和应用
US20230203017A1 (en) * 2021-12-28 2023-06-29 Kamal D. Mehta Protein Kinase C Beta Inhibitors and Uses Thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5373501A (en) * 1976-12-11 1978-06-30 Kitasato Inst Novel antibiotics amm2282 and process for preparing same
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ｕｃｎ―０１
IL86632A0 (en) * 1987-06-15 1988-11-30 Ciba Geigy Ag Derivatives substituted at methyl-amino nitrogen
AU605304B2 (en) * 1987-06-22 1991-01-10 Nihon Tokushu Nayaku Seizo K.K. Benzo-fused cyclic compounds
CA2015996C (fr) * 1989-05-05 2001-08-28 Hartmut Osswald Derives de bis-(1h-indole-3-yl)-maleinimide et leur utilisation comme produits pharmaceutiques

Also Published As

Publication number Publication date
SK278989B6 (sk) 1998-05-06
FI890652A0 (fi) 1989-02-10
CA1320194C (fr) 1993-07-13
IS3433A7 (is) 1989-08-11
SK75289A3 (en) 1998-05-06
FI96861C (fi) 1996-09-10
EP0328026B1 (fr) 1993-04-28
HUT49348A (en) 1989-09-28
JPH01233281A (ja) 1989-09-19
IL89167A (en) 1994-02-27
DK55889A (da) 1989-08-11
NO172540C (no) 1993-08-04
YU47101B (sh) 1994-12-28
PT89661A (pt) 1989-10-04
PH25185A (en) 1991-03-27
CZ280738B6 (cs) 1996-04-17
AU2965889A (en) 1989-08-10
DE58904168D1 (de) 1993-06-03
NZ227850A (en) 1991-11-26
NO890568L (no) 1989-08-11
ES2054890T3 (es) 1994-08-16
YU28489A (en) 1991-06-30
HU201054B (en) 1990-09-28
MC2010A1 (fr) 1990-02-16
EP0328026A1 (fr) 1989-08-16
CZ75289A3 (en) 1995-12-13
AU623630B2 (en) 1992-05-21
FI890652A (fi) 1989-08-11
IE63489B1 (en) 1995-05-03
IL89167A0 (en) 1989-09-10
IE890416L (en) 1989-08-10
PT89661B (pt) 1994-02-28
NO890568D0 (no) 1989-02-09
DK171891B1 (da) 1997-08-04
DK55889D0 (da) 1989-02-07
NO172540B (no) 1993-04-26
FI96861B (fi) 1996-05-31
IS1941B (is) 2004-07-30
US5057614A (en) 1991-10-15
JPH0730071B2 (ja) 1995-04-05

Similar Documents

Publication Publication Date Title
DZ1323A1 (fr) Dérivé du pyrolle.
FI912924A (fi) Laddade organiska polymermikropaerlor i pappersframstaellningsprocess.
FI913886A0 (fi) Pressparti i en pappersmaskin.
FI902263A0 (fi) Temperaturkompensation i en helix-resonator.
FI900937A (fi) Anordning foer axiallagret i en borrmaskin.
FI902908A0 (fi) Matrisfilmstruktur i synnerhet foer elektroluminecens displayenhet.
FI914255A0 (fi) I uv-ljus haerdbar organopolysil- oxankomposition.
FI900987A0 (fi) Anordning i verktygsmaskiner.
FI893193A0 (fi) Kompositioner.
FI900858A0 (fi) Abonnent-telefonanordning.
FI903165A0 (fi) Lagringssystem i automatlager.
FI903033A0 (fi) Taket i en jaernvaegsvagn.
FI906158A0 (fi) Saekerhetslaos avsett foer luckorna i tvaettmaskinstrumman.
FI901348A0 (fi) Maetningsfoenster i maetcell.
FI901608A0 (fi) Frammatningsanordning foer traed i skogsarbetsmaskinens flerfunktionsdel.
IT8921081V0 (it) Il tartiniere.
IT9017927A0 (it) Quadriciclo sbilanciato dentro.
FI905895A (fi) Maongcylindertork i en pappersmaskin.
FI910336A0 (fi) I vaeggelementproduktion anvaendbart oeppningsformsystem.
FI903694A (fi) I backhoppning anvaent staolfartspaor.
FI903797A0 (fi) Laos- och tillslutningsmekanism foer en glidplatta i en kassett.
FI912479A0 (fi) Sjaelvborrande skruv foer traedelar i faestorgan.
FI904030A (fi) Anordning foer hydraulisk krets i traevarubil.
FI904626A (fi) Kylavdelning foer glasskivor i en haerdningsanlaeggning.
FI900120A0 (fi) Arrangemang foer tillbehoerutrymme i lastbil.